|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,259.00 INR | +1.53% |
|
+3.41% | +11.00% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 64TCr 670.43Cr 580.66Cr 541.28Cr 497.84Cr 939.84Cr 950.34Cr 6.36TCr 2.5TCr 32TCr 2.52TCr 2.46TCr 1,05600Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.2x |
|---|---|---|---|---|---|
| Enterprise Value | 60TCr 629.11Cr 544.87Cr 507.92Cr 467.15Cr 881.91Cr 891.76Cr 5.97TCr 2.34TCr 30TCr 2.36TCr 2.31TCr 99TCr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.71x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.53% | ||
| 1 week | +3.41% | ||
| Current month | +1.12% | ||
| 1 month | +2.17% | ||
| 3 months | -5.63% | ||
| 6 months | +15.30% | ||
| Current year | +11.00% |
| 1 week | 2,162 |  | 2,270.2 |
| 1 month | 2,162 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.53% | +3.41% | +8.87% | +181.13% | 660.09Cr | |
| -1.22% | -1.86% | +18.18% | +70.33% | 4.95TCr | |
| -1.75% | +3.69% | +60.31% | +127.28% | 4.01TCr | |
| -0.08% | +0.98% | -3.72% | +20.59% | 1.24TCr | |
| -0.79% | +1.99% | +16.92% | +72.54% | 1.18TCr | |
| +1.72% | -0.76% | +31.31% | +133.18% | 910.08Cr | |
| +1.34% | +3.50% | +15.77% | +33.96% | 693.63Cr | |
| -0.26% | -4.80% | +39.24% | -14.13% | 688.06Cr | |
| +0.79% | +4.47% | -31.29% | +15.81% | 562.8Cr | |
| -2.49% | +2.85% | +30.39% | +96.77% | 462.82Cr | |
| Average | -0.13% | +1.63% | +18.60% | +73.75% | 1.54TCr | |
| Weighted average by Cap. | -0.75% | +1.75% | +27.07% | +83.20% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 161.02Cr 139.46Cr 130Cr 119.57Cr 225.73Cr 228.25Cr 1.53TCr 599.6Cr 7.66TCr 604.77Cr 591.44Cr 25TCr | 17TCr 176.68Cr 153.02Cr 142.64Cr 131.19Cr 247.68Cr 250.44Cr 1.68TCr 657.9Cr 8.41TCr 663.57Cr 648.94Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 31Cr 204.86Cr 80Cr 1.03TCr 81Cr 79Cr 3.4TCr | 2.33TCr 25Cr 21Cr 20Cr 18Cr 34Cr 35Cr 232.91Cr 91Cr 1.17TCr 92Cr 90Cr 3.87TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -31Cr -58Cr -59Cr -392.06Cr -153.88Cr -1.97TCr -155.21Cr -151.78Cr -6.51TCr | -1.45TCr -15Cr -13Cr -12Cr -11Cr -21Cr -22Cr -144.41Cr -57Cr -724.16Cr -57Cr -56Cr -2.4TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | ₹2,259.00 | +1.53% | 3,88,492 |
| 04/26/04 | ₹2,225.00 | -0.22% | 4,44,946 |
| 03/26/03 | ₹2,230.00 | -0.17% | 13,07,223 |
| 31/26/31 | ₹2,233.90 | +1.99% | 3,71,153 |
| 30/26/30 | ₹2,190.30 | -3.16% | 4,51,791 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
